Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:269573
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic syndromes with corpus callosum agenesis or dysgenesis as a major feature represent a broad category of rare genetic conditions in which the corpus callosum — the large bundle of nerve fibers connecting the left and right hemispheres of the brain — fails to develop normally (agenesis) or develops incompletely (dysgenesis). This grouping, classified under Orphanet code 269573, encompasses numerous distinct genetic syndromes where this brain malformation is a defining or prominent clinical characteristic rather than an incidental finding. The corpus callosum plays a critical role in interhemispheric communication, and its absence or malformation can lead to a wide range of neurological and developmental consequences. Clinical features vary considerably depending on the specific underlying syndrome but commonly include intellectual disability of variable severity, developmental delay, seizures or epilepsy, motor coordination difficulties, and speech and language impairments. Many of these syndromes also involve additional organ systems, with associated features potentially including craniofacial anomalies, skeletal malformations, cardiac defects, ocular abnormalities, and growth disturbances. Some well-known syndromes within this category include Aicardi syndrome, Mowat-Wilson syndrome, Acrocallosal syndrome, and Andermann syndrome, among many others. Each has its own distinct genetic basis, inheritance pattern, and constellation of associated features. There is currently no cure or specific treatment that can restore normal corpus callosum development. Management is supportive and multidisciplinary, tailored to the specific syndrome and the individual patient's needs. This may include antiepileptic medications for seizure control, physical and occupational therapy for motor difficulties, speech-language therapy, special education services, and surgical interventions for associated structural anomalies. Early intervention programs and regular developmental monitoring are important components of care. Genetic counseling is recommended for affected families to clarify the specific diagnosis, inheritance pattern, and recurrence risk.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature.

View clinical trials →

No actively recruiting trials found for Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature community →

No specialists are currently listed for Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Genetic syndrome with corpus callosum agenesis/dysgenesis as a major featureForum →

No community posts yet. Be the first to share your experience with Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature.

Start the conversation →

Latest news about Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature

No recent news articles for Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature

What is Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature?

Genetic syndromes with corpus callosum agenesis or dysgenesis as a major feature represent a broad category of rare genetic conditions in which the corpus callosum — the large bundle of nerve fibers connecting the left and right hemispheres of the brain — fails to develop normally (agenesis) or develops incompletely (dysgenesis). This grouping, classified under Orphanet code 269573, encompasses numerous distinct genetic syndromes where this brain malformation is a defining or prominent clinical characteristic rather than an incidental finding. The corpus callosum plays a critical role in inter